(2'R,6'R,8E,10E,14Z,16E,3R,4R,5R,6S,7R,13R)-(+)-4-tert-butyldimethylsilyloxy-17-(5',6'-dihydro-2'H-2'-isopropoxypyran-6'-yl)-15-ethyl-6-hydroxy-3,5,7,9,13-pentamethylheptadeca-8,10,14,16-tetraene

C19-epi-C19-triisopropylsilyl callystatin A

(8E,10E,14Z,16E)-[3S,4R,5R,7R,13R,17(2R)]-4-(tert-butyldimethylsilanyloxy)-15-ethyl-17-(6-hydroxy-3,6-dihydro-2H-pyran-2-yl)-3,5,7,9,13-pentamethylheptadeca-8,10,14,16-tetraen-6-ol

(2S,3S,4R,6S)-6-[(2E,4E,8Z,10E)-(1R,7R)-1-Hydroxy-11-((2R,6R)-6-isopropoxy-3,6-dihydro-2H-pyran-2-yl)-5,7,9-trimethyl-undeca-2,4,8,10-tetraenyl]-3-methyl-2-((E)-propenyl)-tetrahydro-pyran-4-ol

(2R,6R)-6-{(1E,3Z,7E,9E)-(5R,11R)-11-Hydroxy-11-[(2S,4R,5S,6S)-4-hydroxy-5-methyl-6-((E)-propenyl)-tetrahydro-pyran-2-yl]-3,5,7-trimethyl-undeca-1,3,7,9-tetraenyl}-5,6-dihydro-2H-pyran-2-ol